MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT06954337
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Usual practice pattern (UPP) — OTHERPatient follows usual practice pattern for routine care
- Experimental: Enhanced Telehealth (ET) — OTHERPatient follows enhanced telehealth practice pattern. As clinically appropriate, patients given option to shift routine care from face-to-face to at-home services available at institution: telehealth visits, home phlebotomy, and educational support for home administration of injection medications
Study Details
Many people with cancer spend a lot of time and money traveling to and from the doctor's office for cancer care. MSK's goal is to make getting cancer care easier by cutting down the need to make in-person visits to MSK. MSK is trying to do this through a new option called enhanced telehealth.
Key Dates
- Start date
- May 1, 2025
- Status verified
- Dec 2025
- Primary completion
- Mar 1, 2027
- Completion
- May 1, 2027
Study Design
- Enrollment
- 1,750 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Active Comparator: Usual practice pattern (UPP)Usual practice pattern (UPP) of patient's medical oncologist
- Experimental: Enhanced Telehealth (ET)Enhanced Telehealth (ET) practice pattern of patient's medical oncologist
Primary Outcome Measure
Proportion of routine face to face medical oncology related visits out of total medical oncology related visits [ Time Frame: 12 months ]
Central Contacts
- Erin Bange, MD, MSCE646-422-4680
- Deborah Schrag, MD, MPH212-639-5851
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (All Protocol Activities) | Basking Ridge | New Jersey | 07920 | Erin Bange, MD, MSCE 646-422-4680 |
| Memorial Sloan Kettering Monmouth (All Protocol Activities) | Middletown | New Jersey | 07748 | Erin Bange, MD, MSCE 646-422-4680 |
| Memorial Sloan Kettering Bergen (All Protocol Activities) | Montvale | New Jersey | 07645 | Erin Bange, MD, MSCE 646-422-4680 |
| Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) | Commack | New York | 11725 | Erin Bange, MD, MSCE 646-422-4680 |
| Memorial Sloan Kettering Westchester (All Protocol Activities) | Harrison | New York | 10604 | Erin Bange, MD, MSCE 646-422-4680 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activites) | New York | New York | 10065 | Erin Bange, MD, MSCE 646-422-4680 |
| Memorial Sloan Kettering Nassau (All Protocol Activities) | Uniondale | New York | 11553 | Erin Bange, MD, MSCE 646-422-4680 |
Find similar trials in Basking Ridge, NJ
By condition
By research site
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (All Protocol Activities)· Middletown, NJMemorial Sloan Kettering Bergen (All Protocol Activities)· Montvale, NJMemorial Sloan Kettering Suffolk - Commack (All Protocol Activities)· Commack, NYMemorial Sloan Kettering Westchester (All Protocol Activities)· Harrison, NYMemorial Sloan Kettering Cancer Center (All Protocol Activites)· New York, NY
Related Studies
- [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate CancerRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA MutationsRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerPHASE2 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona